Jianfeng Group Lin2016 -011 (Related Transaction of Capital Increase of Jianfeng Pharmaceutical)
Release time:
2020-08-05
Securities Code: 600668 Securities Abbreviation: Jianfeng Group No.: Lin 2016-011
Bond Abbreviation: 13 Peak 01 Bond Code: 122227
Bond Abbreviation: 13 Peak 02 Bond Code: 122344
Zhejiang Jianfeng Group Co., Ltd.
Announcement on Related Party Transactions of Capital Increase in Jianfeng Pharmaceutical
The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and assumes individual and joint responsibility for the truthfulness, accuracy and completeness of its contents .
Overview of 1. Related Party Transactions
(I) On April 5, 2016 , the board of directors of Zhejiang Jianfeng Pharmaceutical Co., Ltd. (hereinafter referred to as "Jianfeng Pharmaceutical"), a holding subsidiary of the Company, made a resolution, it is proposed to use the audited consolidated statement at the end of 2015 attributable to the owner of the parent company equity 30137.64 yuan as the basis for the monetary capital increase, the total amount of this capital increase is 100 million yuan. The Company holds a 99.16 equity interest in Peak Pharmaceuticals, and the amount of capital increase enjoyed by the Company is $99.16 million. Jinhua Tongji State-owned Assets Investment Co., Ltd. (hereinafter referred to as "Tongji State Investment") holds a 0.84 per cent stake in Jianfeng Pharmaceutical, and the amount of capital increase enjoyed by Tongji State Investment is 840000 yuan.
(II) Tongji Guotou holds 16.15 equity of the company and is the controlling shareholder of the company. Mr. Jiang Xiaomeng, chairman of the company, is also a director of Tongji Guotou. According to the relevant provisions of the Shanghai Stock Exchange Stock Listing Rules, Tongji Guotou is a related legal person of the company, and joint investment with related parties is a related transaction.
(III) the amount of this related party transaction is 9916 yuan, exceeding 30 million yuan, but it does not reach 5% of the absolute value of the company's audited net assets in 2015. this related transactions do not constitute a major asset restructuring of the listing Corporation's major asset restructuring management approach.
2. Related Party Introduction
1 , Name: Jinhua Tongji State-owned Assets Investment Co., Ltd.
2 , Nature of Enterprise: Limited Liability Company (Wholly State-owned)
3 , Place of Registration: no. 64 4
, 1st floor, No. 1389 Danxi Road, Jinhua City, Zhejiang Province, main office location: No. 695 , 1st floor, No. 1389 Danxi Road, Jinhua City, Zhejiang Province, legal representative: Liu Bo
6 , registered capital: RMB 9500 Yuan
7 , main business: general business items: authorized investment and operation of state-owned assets.
8 , Main Financial Indicators of Related Persons in Recent Year
As of December 31, 2015 , Tongji Guotou had total assets of 358.7316 million yuan, net assets of 342.4002 million yuan and net profit of 14.8026 million yuan.
Basic Information of 3. Jianfeng Pharmaceutical
, Basic Information of Transaction Target
(1 ) Name: Zhejiang Jianfeng Pharmaceutical Co., Ltd.
(2 ) Enterprise Nature: Limited Liability Company
(3 ) Registration Place: main office location of
(4 ) on the second floor of X02 office quality inspection building, No. 58 Gaofan section, Baitang downline, Wucheng district, Jinhua city, Zhejiang province:
(5 ) on the fourth-fifth floor of Jianfeng building, No. 88 Wujiang east road, Jinhua city, Zhejiang province legal representative: Jiang Xiaomeng
(6 120) registered capital: RMB 149.07 million yuan
(7) main business: drug research and development and production (operating with valid license); Import of raw and auxiliary materials for production and scientific research; Imported mechanical equipment, instruments and spare parts. (For projects subject to approval according to law, business activities can only be carried out after approval by relevant departments)
2, main financial data of the transaction target (unit: ten thousand yuan)
subject
2015 # December 31, 142 |
total assets |
| 104765.48 |
total liabilities |
| 70945.02 |
Ownership of Parent Company Owner's Equity |
| 30137.64 |
Asset-Liability Ratio |
| 67.72% |
|
| Year | Operating Income |
| 113292.85 |
Net Profit Attributable to Owner of Parent Company |
| 5924.42 |
Principles and Methods for Price Determination of (I) Related Party Transactions
This capital increase is to be based on the owner's equity attributable to the parent company after the annual audit of Jianfeng Pharmaceutical 2015 .
(II)'s total capital increase this time is 10,000
.49 million yuan, and the company enjoys the capital increase right of 99.16 million yuan according to its shareholding ratio. Tongji Guotou enjoys the capital increase right of 840000 yuan according to its shareholding ratio. If both parties are fully funded, after the completion of the capital increase, the registered capital of Jianfeng Pharmaceutical will increase to 198.53 million yuan, of which Jianfeng Pharmaceutical will account for 99.16 percent and Tongji Guotou will account for 0.84 percent.The amount of capital increase subscribed by the (III) capital increase party shall be remitted to Jianfeng Pharmaceutical's account before June 30, 2016
.5. the purpose of the related party transaction and its impact on the listed company
Jianfeng Pharmaceutical is a controlling subsidiary of the company, and its pharmaceutical business is one of the company's two main businesses. With the continuous expansion of the development scale, the demand for funds is also increasing, especially after the investment of Jinxi project, the debt ratio of Jianfeng Pharmaceutical is on the high side, the capital increase of Jianfeng Pharmaceutical will help improve its asset structure, enhance its strength and competitiveness, and will contribute to the healthy and sustainable development of the company's pharmaceutical industry.
6. the review procedure to be performed for the related party transaction
On April 8, 266, 2016 , the company held the 6th meeting of the 9th board of directors, and all eight directors of the company attended the meeting in person. Mr. Jiang Xiaomeng, the related director, avoided voting on the proposal, which is in line with the relevant provisions of the Company Law and the Articles of Association of the company, the resolutions made are legal and valid. After deliberation and voting, the board of directors deliberated and passed the "related party transaction proposal on capital increase of Jianfeng pharmaceutical" with 7 votes in favor, 0 against and 0 abstention. It was agreed that the company would invest 99.16 million yuan to increase the capital of Peak Pharmaceuticals.
The amount of this related party transaction has not reached 5% of the absolute value of the audited net assets of the company in 2015
. According to the company's "Articles of Association", it does not need to be submitted to the general meeting of shareholders for approval. Beforethe board of directors, the company reported to the independent directors, and the independent directors made a prior approval statement, believing that the capital increase price of the related party transaction was determined on the basis of the audited net assets and enjoyed the capital increase right according to the shareholding ratio of each shareholder, and that the company could ensure that its share of equity would not be reduced after participating in the capital increase. After the implementation of the related party transaction, it will effectively optimize the asset structure of the invested company, enhance the strength of the enterprise, enhance the competitiveness, and ensure the sustainable and healthy development of the enterprise. The above related party transactions did not harm the interests of the company and shareholders, and agreed to submit the proposal to the 6th 275 meeting of the ninth board of directors of the company for deliberation. The independent directors expressed their independent opinions on the resolution made by the board of directors, and believed that the formation of the resolution complied with the "Company Law", the "Articles of Association" and other relevant provisions, and did not harm the interests of small and medium shareholders.
The audit committee of the company's board of directors issued a written review opinion on the related transaction, and believed that the relevant information on the related transaction was complete and the company's management had conducted comprehensive communication with it. The related party transaction belongs to the normal economic behavior of the company and meets the needs of the company's operation and development; the price of capital increase is determined according to the audited net assets, and the capital increase right is enjoyed according to the shareholding ratio of each shareholder. After the capital increase, the company's equity share of the invested unit will not decline; the transaction follows the principles of fairness, impartiality, voluntariness and good faith, and does not harm the interests of the company and shareholders.
Tongji Company's participation in this capital increase still needs to be approved by its competent authorities and departments.6. Online Announcement Annex
(I) Statement Approved in advance by Independent Directors
(II) Independent Director Opinion Signed and Confirmed by Independent Directors
(III) Written Review Opinion of Audit Committee of Board of Directors on Related Party Transactions
Financial Statements and Audit Report of (IV) Jianfeng Pharmaceutical
hereby announce
April 12, 2016
More information
Daye Peak Won "Advanced Manufacturing Brand" in Huangshi City"
On the occasion of the fifth "China Brand Day", the office of Huangshi City Quality Strong City Working Committee held a grand awarding ceremony of "Promoting the High-quality Development of Huangshi 70 Brands", and Daye Jianfeng Cement Company was awarded the "Advanced Manufacturing Brand". In order to revitalize the post-epidemic economy and enhance the confidence of enterprises, Huangshi City Quality Strong City Working Committee Office organized and carried out a large-scale news investigation, publicity and exhibition activity of "Huangshi Glory, the era of glory-the 70th anniversary of the founding of the city, promoting the high-quality development of Huangshi 70 brands", aiming at vigorously publicizing the major achievements and advanced models of the high-quality development of various industries in Huangshi and the construction of strong quality strong quality city, and encouraging enterprises, and leading enterprises to further establish the strong quality, help Yellowstone "five city construction", cohesion of economic and social high-quality development of a strong force. After the public vote, the 70 brands and 30 characteristic brands selected to promote the high-quality development of Huangshi in the 70 years since the establishment of the city were awarded the advanced manufacturing brand, modern service brand, high-quality education brand, excellent cultural brand, modern agricultural brand and Huangshi high-quality development characteristic brand respectively. Daye Peak won the honor of "advanced manufacturing brand.
2021
05-21
Learning Party History, Strong Faith
On April 29, the staff of the peak building stopped to browse when they passed the newly created party history knowledge propaganda wall. 2021 is the 100 anniversary of the founding of the Communist Party of China, the Central Committee called on the whole party to carry out the study and education of party history. Since the party committee of the group company deployed the party history study and education work, party organizations at all levels of the company have taken active actions to further strengthen their ideals and beliefs through various forms such as special party classes, concentrated study, visiting the red education base, and reviewing the oath of joining the party.
2021
05-06
Cement industry, Huangshi City two honors flower daye peak
In April, China's cement industry and Huangshi City in Hubei Province each won an honor by Daye Peak, and the company's work in environmental protection and poverty alleviation was affirmed. The 2021 China Cement Industry Summit held in Hangzhou from April 20 to 21, with the theme of "common mission, innovation and common development", discussed the current development trend of the cement industry in depth. During the meeting, a series of awards for the top 100 cement industry were held. After reviewing multi-dimensional information such as brand growth, brand productivity, brand awareness and brand reputation, daye peak was awarded the title of "enterprise with outstanding contribution to environmental protection. Recently, Huangshi City Federation of Industry and Commerce (Chamber of Commerce) held the 6th Executive Committee of the 12th session to review the work in 2020 and deploy the targets and tasks for 2021. It commended the city's advanced collective of "precise poverty alleviation and private enterprise assistance". Daye Peak was awarded the honorary title of "Advanced Private Enterprise.
2021
05-06
Yang Zhi, head of Huangping County, Guizhou Province, visited Jianfeng
On April 16, a delegation led by Yang Zhi, head of Huangping County, Guizhou Province, visited the headquarters of the group company and held discussions with the group leaders on the future development of Huangping peak and further strengthening the in-depth cooperation between the two sides. During the exchange, Chairman Jiang Xiaomeng introduced the development of Jianfeng in recent years, which aroused unanimous praise from the members of the delegation. Yang Zhi said that Jianfeng is an enterprise with a sense of social responsibility and serious business. He hopes to further cooperate in other industrial fields to promote the economic development of Huangping.
2021
04-21
The Pursuit and Dream of the Spike of "Egoist" of "Lie to the People"
On March 23, China Cement Network published an exclusive interview with Jiang Xiaomeng, chairman of the group company, under the title of "the pursuit and Dream of the peak of self-interest. During the interview, Jiang Xiaomeng expressed his views on the future development trend of China's cement industry and introduced the development ideas of the peak cement industry in the future. The full text of this article is reproduced here...
2021
04-12
Daye Peak Won the Title of "Charity Enterprise" in Daye City
Daye city recently organized the 2020 Metallurgical Conference to review and summarize the 2020 Metallurgical Work and arrange the deployment of 2021. Wang Gang, secretary of the Daye Municipal Party Committee, attended the conference and made an important speech, in particular, he expressed his heartfelt thanks to a group of enterprises and entrepreneurs, such as Jinpai Company and Daye Peak, for coming forward, giving generously and helping at the most critical juncture of Daye epidemic prevention and control. The conference announced the "Decision of Daye Municipal Party Committee and Municipal Government on Releasing the 2020 Charity Contribution List" and commended it on the spot. Daye Peak and other enterprises were awarded the honorary title of "2020 Charity Enterprise. Zhang Fengliang, deputy general manager of the group company and general manager of Daye Peak, accepted the commendation on behalf of Daye Peak and delivered a keynote speech at the meeting as a representative of the commended enterprise. (Daye Peak)
2021
04-12